Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
FOR-HL-25-028The NHLBI is planning to release a funding opportunity for single site clinical trials that involve novel and innovative designs such as platform, adaptive, and Bayesian trials. These trials can focus on testing various therapeutic, behavioral, or prevention strategies. The trials must align with NHLBI's research goals and the NIH's clinical trial definition. Although applications are not bein…
The NHLBI intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials using innovative…
Source
Eligibility
Tags
Supporting links
Similar opportunities
-
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
-
Notice of Funding Opportunity (NOFO) for Investigator-Initiated Single Site Clinical Trials
-
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
-
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
-
NIAMS UG3/UH3 Cooperative Agreement for Clinical Trials